• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cancer gene therapy by the in vivo transfer of cytokine-genes in to the artery that leads to tumors with fusogenic liposomes.

Research Project

Project/Area Number 09557194
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Biological pharmacy
Research InstitutionOsaka University

Principal Investigator

MAYUMI Tadanori  School of Pharmaceutical Sciences Osaka University Professor, 薬学研究科, 教授 (00098485)

Co-Investigator(Kenkyū-buntansha) TSUTSUMI Yasuo  School of Pharmaceutical Sciences Research Associate, 薬学研究科, 助手 (50263306)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 1998: ¥3,800,000 (Direct Cost: ¥3,800,000)
KeywordsGenethetrapy / tumor immune / Cytokine / Fusogenic liposomes
Research Abstract

We report that tumor necrosis factor (TNF) alpha induced a strong antitumor immune reaction when it was produced in arteries leading to tumors by gene transfer in vivo. We used a mouse model carrying a sarcoma-18O tumor in the right footpad and injected the fusogenic liposomes encapsulating the human TNF-alpha gene into the right femoral artery. Under this condition, human TNF-alpha was detected only in the artery leading to the tumor and in the tumor. There was a significant regression in tumor growth when the TNF-alpha gene was delivered into the right femoral artery, with 4 of 11 mice completely cured. No regression was observed when the TNF-alpha gene was delivered into the left femoral artery or into the tumor or when the luciferase gene was administered. Tumor regression was inhibited by the injection of anti-TNF-alpha, anti-CD4, or anti-CD 8 monoclonal antibody, and CD8+ T cells accumulated in the tumors of TNF-alpha-treated mice. These results suggest that TNF-alpha expressed l … More ocally in the arteries leading to tumors efficiently suppresses tumor growth through reinforcement of an antitumor immune reaction. Additionally, Development of methodologies for gene transfer into the central nervous system (CNS) is important for fundamental research as well as clinical studies for gene therapy. Cationic liposomes (CL) are attractive vectors because of their safety and ease of use. However, to date only low rates of success have been reported. We succeeded in obtaining high transfection efficiencies into the newborn mouse brain in vivo by CL and a cytoplasmic gene expression system based on T7 RNA polymerase and T7 RNA polymerase- and the luciferase-gene with the T7 promoter sequence. This system showed an efficiency rate 2 orders of magnitude higher than the standard system, which used CL and luciferase genes with a Rous sarcoma virus promoter, pRSVL.In addition, in vitro experiments using LLCMK2 cells showed that cytoplasmic gene expression occurred rapidly (within 6 h) after transfection. In contrast, pRSVL required 24-48 h for induction of luciferase expression. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Mayumi T.et al.: "Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes in to the artery that leads to tumors." Cancer Res.58. 5725-5730 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mayumi T.et al.: "Possibility of cytomedical therapy for diabetes melitus using microcapsulated pancreatic β cell line with glucose sensor." Drug Delivery System. 13. 95-100 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mayumi T.et al.: "The optimization of cytoplasmic gene expression system with T7 RNA polymerase." Drug Delivery System. 13. 87-93 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mayumi T.et al.: "Development of VSV-liposomes as a novel gene transfer vector" Drug Delivery System. 13. 159-164 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mayumi T.et al.: "Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain." Biochem.Biophys.Res.Commun.234. 15-18 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mayumi T.et al.: "Immunological studies of SK2 hybridoma cells microencapsulated with alginatepoly(L)lysine-alginate(APA)membrane following allogeneic transplantation." Biochem.Biophys.Res.Commun.230. 524-527 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mizuguchi H., Nakagawa T., Toyosawa S., Nakanishi M., Imazu S., Nakanishi T., Tsutsumi Y., Nakagawa S., Hayakawa T., Ijuhin N., and Mayumi T.: "Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes in to the artery that leads to tumors." Cancer Res.58. 5725-5730 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshioka T., Okada N., Miyamoto H., Sakamoto K., Tsutsumi Y., Nakagawa S., Miyazaki J., Mayumi T.: "Possibility of cytomedical therapy for diabetes melitus using microcapsulated pancreatic beta cell line with glucose sensor." Drug Delivery System. 13. 95-100 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Suzuki R., Nakagawa T., Mizuguchi H., Imazu S., Nakanishi T., Nakagawa S., Nakanishi M., and Mayumi T.: "The optimization of cytoplasmic gene expression system with T7 RNA polymerase." Drug Delivery System. 13. 87-93 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Imazu S., Nakagawa S., Nakanishi T., Hayakawa T., Uemura H., Yamada O., and Mayumi T.: "Development of VSV-liposomes as a novel gene transfer vector." Drug Delivery System. 13. 159-164 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mizuguchi H., Nakagawa T., Morioka Y., Imazu S., Nakanishi M., Kondoh T., Hayakawa T., Mayumi T.: "Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain." Biochem.Biophys.Res.Commun.234. 15-18 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Okada N., Miyamoto H., Yoshioka T., Sakamoto K., Katsume A., Saito H., Nakagawa S., Ohsugi Y., Mayumi T.: "Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly (L) lysine-alginate (APA) membrane following allogeneic transplantation." Biochem.Biophys.Res.Commun.230. 524-527 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mayumi T.et al.: "Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes on to the artery that leads to tumors." Cancer Res.58. 5725-5730 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tsutsumi Y.et al.: "Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA)membrane following allogeneic transplantation." Biochem.Biophys.Res.Commun.230. 524-527 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mayumi T.et al.: "Possibility of cytomedical therapy for diabetes melitus using microcapsulated pancreatic β cell line with glucose sensor." Drug Delivery System. 13. 95-100 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mayumi T.et al.: "The optimization of cytoplasmic gene expression system with T7 RNA polymerase." Drug Delivery System. 13. 87-93 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mayumi T.et al.: "Development of VSV-liposomes as a novel gene transfer vector" Drug Delivery System. 13. 159-164 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mayumi T.et al.: "Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain." Biochem.Biophys.Res.Commun.234. 15-18 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Mayumi T.et al.: "Gene transfer vectors based on Sendai virus." J.Control.Release.(in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] Mayumi T.et al.: "Development of VSV-liposomes as a novel gene transfer vector" Drug Delivery System. (in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] Mayumi T.et al.: "Fusogenic liposome directs an exogenous antigen into class l majour histcompatibility complex antigen-presenting pathway." Drug Delivery System. (in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] Mayumi T.et al.: "Enhancement of liposomal adjuvant actions for tumor vaccines by increasing the degree of surface charge." Drug Delivery System. (in press).

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi